Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

Also called NCT05378347

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05378347
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Finland, France, Germany, Greece, Italy, Japan, Netherlands, Spain, Switzerland, Taiwan, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05378347. Randomized; single masking; primary purpose treatment. Start 2023-01-05 (actual); primary completion 2027-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Acronym
ADVANCE
Condition
Abdominal Aortic Aneurysm
Condition
Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
Condition
Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Intervention (Device)
Medtronic Endurant II or Endurant IIs Stent Graft System
Intervention (Device)
Gore Excluder or Gore/ Excluder Conformable AAA Endoprosthesis
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct05378347
Content hash
c0259096530b37ba8e45d6fad5e018dd3de799f83e13a4e765d89522439efa96